{"transactions":[{"id":934013,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":69040,"kind":"person","name":"Bray June","position":1,"cik":"0001845487","reported_name":"Bray June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-01-21T22:59:06.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":18724,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in equal quarterly installments over a one year-period. The Reporting Person elected to receive the stock options in lieu of the annual director cash retainer for 2026 provided for under the Issuer's Outside Director Compensation Policy."}],"balance_after":18724,"derivative":{"exercise_price":3,"expiration_date":"2036-01-02","underlying":"Common Shares","underlying_shares":18724},"source":{"system":"sec-edgar","filing":"0000912282-26-000083","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000091228226000083/form4.xml","form_type":"4"}},{"id":940700,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":69040,"kind":"person","name":"Bray June","position":1,"cik":"0001845487","reported_name":"Bray June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-13T00:01:13.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date."}],"balance_after":17000,"derivative":{"exercise_price":2.01,"expiration_date":"2036-01-09","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001104659-26-002975","document":"tm262917-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720893/000110465926002975/tm262917-2_4seq1.xml","form_type":"4"}},{"id":1119125,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":69040,"kind":"person","name":"Bray June","position":1,"cik":"0001845487","reported_name":"Bray June","relationship":{"director":true}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-06T21:07:25.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest 100% on the one-year anniversary of the grant date.  The Reporting Person elected to receive the stock options in lieu of the annual director cash retainer for 2025 provided for under the issuer's Outside Director Compensation Policy."}],"balance_after":27000,"derivative":{"exercise_price":1.09,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0000912282-25-000613","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000091228225000613/form4.xml","form_type":"4"}},{"id":1306350,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":69040,"kind":"person","name":"Bray June","position":1,"cik":"0001845487","reported_name":"Bray June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-01-09T00:32:09.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":30282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in equal quarterly installments over a one year-period. The Reporting Person elected to receive the stock options in lieu of the annual director cash retainer for 2025 provided for under the Issuer's Outside Director Compensation Policy."}],"balance_after":30282,"derivative":{"exercise_price":1.88,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":30282},"source":{"system":"sec-edgar","filing":"0001415889-25-001163","document":"form4-01092025_120106.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000141588925001163/form4-01092025_120106.xml","form_type":"4"}},{"id":1482880,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":69040,"kind":"person","name":"Bray June","position":1,"cik":"0001845487","reported_name":"Bray June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-11T23:00:11.000Z","date":"2024-06-10","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date."}],"balance_after":17000,"derivative":{"exercise_price":1.44,"expiration_date":"2034-06-10","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001104659-24-070514","document":"tm2416928-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720893/000110465924070514/tm2416928-1_4seq1.xml","form_type":"4"}},{"id":1486073,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":69040,"kind":"person","name":"Bray June","position":1,"cik":"0001845487","reported_name":"Bray June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-06-08T00:59:30.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to this stock option will vest on the one-year anniversary of the grant date."}],"balance_after":27000,"derivative":{"exercise_price":0.82,"exercise_date":"2025-06-05","expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001415889-24-016089","document":"form4-06082024_120627.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000141588924016089/form4-06082024_120627.xml","form_type":"4"}},{"id":1842485,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":69040,"kind":"person","name":"Bray June","position":1,"cik":"0001845487","reported_name":"Bray June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-28T21:02:39.000Z","date":"2023-06-26","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date."}],"balance_after":17000,"derivative":{"exercise_price":17.52,"expiration_date":"2033-06-26","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001104659-23-075875","document":"tm2319786-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720893/000110465923075875/tm2319786-6_4seq1.xml","form_type":"4"}},{"id":1875868,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":69040,"kind":"person","name":"Bray June","position":1,"cik":"0001845487","reported_name":"Bray June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-26T21:45:03.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the stock option shall vest in equal annual installments over the three-year period following the grant date of May 24, 2023."}],"balance_after":27000,"derivative":{"exercise_price":1.58,"expiration_date":"2033-05-23","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001209191-23-032671","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919123032671/doc4.xml","form_type":"4"}},{"id":2235306,"issuer":{"id":7403,"kind":"organization","name":"Quince Therapeutics, Inc."},"owners":[{"id":69040,"kind":"person","name":"Bray June","position":1,"cik":"0001845487","reported_name":"Bray June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-10T20:20:18.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the stock option shall vest in equal annual installments over the three-year period following the grant date of June 9, 2022."}],"balance_after":54000,"derivative":{"exercise_price":3.2,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":54000},"source":{"system":"sec-edgar","filing":"0001209191-22-035877","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1662774/000120919122035877/doc4.xml","form_type":"4"}},{"id":2259356,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":69040,"kind":"person","name":"Bray June","position":1,"cik":"0001845487","reported_name":"Bray June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-23T22:50:37.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date."}],"balance_after":17000,"derivative":{"exercise_price":13.24,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001104659-22-063973","document":"tm2216669-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720893/000110465922063973/tm2216669-4_4seq1.xml","form_type":"4"}},{"id":2667541,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":69040,"kind":"person","name":"Bray June","position":1,"cik":"0001845487","reported_name":"Bray June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-15T21:32:52.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full and become exercisable in three substantially equal annual installments following the date of grant, such that the option shall be fully vested on the third anniversary of the date of grant, subject to the Reporting Person's continued service through such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":37.86,"expiration_date":"2031-06-11","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-21-081586","document":"tm2119762-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720893/000110465921081586/tm2119762-5_4seq1.xml","form_type":"4"}},{"id":2811018,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":69040,"kind":"person","name":"Bray June","position":1,"cik":"0001845487","reported_name":"Bray June","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-04T00:01:42.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":4167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on the earlier of the earlier of the first anniversary of March 1, 2021 or the day immediately prior to the start of the next BioXcel Therapeutics, Inc. annual meeting of stockholders, subject to the Reporting Person's continued service through the vesting date."}],"balance_after":4167,"derivative":{"exercise_price":55.71,"expiration_date":"2021-03-01","underlying":"Common Stock","underlying_shares":4167},"source":{"system":"sec-edgar","filing":"0001104659-21-031663","document":"tm217124-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720893/000110465921031663/tm217124-6_4seq1.xml","form_type":"4"}}]}